Clinical trial
Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)
NCT00305604 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00305604 |
|---|---|
| Title | Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED) |
| Official title | A Multicenter, Double-Blind, Randomized, Parallel Group Study to Evaluate the Safety and Efficacy of Sitagliptin in Elderly Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | sitagliptin phosphate, Comparator: Placebo |
| Enrollment | 206 |
| Start date | Mar 8, 2006 |
| Primary completion | Mar 12, 2008 |
| Completion | Mar 12, 2008 |
| First posted | Mar 22, 2006 |
| Last update posted | May 11, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: